Chiaki Masaki
Overview
Explore the profile of Chiaki Masaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okamoto T, Shima H, Noma Y, Komatsu M, Azuma H, Miya K, et al.
Diabetol Int
. 2021 Mar;
12(2):229-233.
PMID: 33786277
Glycated hemoglobin (HbA1c) is an important indicator of glycemic control in patients with diabetes. High-performance liquid chromatography (HPLC) is the most commonly used method for measuring HbA1c levels; as HPLC...
2.
Masaki C, Matsushita K, Inoue T, Shima H, Chikakiyo M, Yamada M, et al.
Semin Dial
. 2021 Feb;
34(3):245-251.
PMID: 33609413
Peritoneal dialysis (PD)-related peritonitis is sometimes complicated with other infections; however, few cases of splenic abscess have been reported. We present the case of a 64-year-old PD patient with complicated...
3.
Masaki C, Ogawa S, Shima H, Banno T, Tsuyuguchi M, Nagasaka N, et al.
CEN Case Rep
. 2020 Oct;
10(2):208-213.
PMID: 33079356
Successful kidney transplantation usually resolves secondary hyperparathyroidism (SHPT). However, some patients fail to normalize, and their condition is often referred to as tertiary hyperparathyroidism (THPT). Surgical consensus on the timing...
4.
Shima H, Okamoto T, Tashiro M, Inoue T, Masaki C, Tanaka Y, et al.
Blood Purif
. 2020 Sep;
50(2):238-245.
PMID: 32892202
Introduction: Hemodialysis patients are at a high risk of bloodstream infection (BSI). The risk factors for BSI-associated mortality, especially of unknown origin, remain uncertain. BSI of unknown origin is highly...
5.
Shima H, Okamoto T, Tashiro M, Inoue T, Masaki C, Tada H, et al.
Kidney Med
. 2020 Aug;
1(2):75-78.
PMID: 32734188
Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or...